Journal of the American Society for Mass Spectrometry · 2017 · 34 citations · 25 references
Life SciencesBiochemistryCarbohydrate ChemistryGlycobiologyMass Spectrometric AnalysisGlycan AnalysisGlycan BiosynthesisGlycan StructureMass SpectrometryPolysaccharide StructureElectron DetachmentGlycan Structural AnalysisGlycan Structure AnalysisGlycosaminoglycan StructureHeterogeneityTandem Mass SpectrometryTandem Mass Spectrometry AnalysisUronic Acid Chemistry
The analysis of heparan sulfate (HS) glycosaminoglycans presents many challenges, due to the high degree of structural heterogeneity arising from their non-template biosynthesis. Complete structural elucidation of glycosaminoglycans necessitates the unambiguous assignments of sulfo modifications and the C-5 uronic acid stereochemistry. Efforts to develop tandem mass spectrometric-based methods for the structural analysis of glycosaminoglycans have focused on the assignment of sulfo positions. The present work focuses on the assignment of the C-5 stereochemistry of the uronic acid that lies closest to the reducing end. Prior work with electron-based tandem mass spectrometry methods, specifically electron detachment dissociation (EDD), have shown great promise in providing stereo-specific product ions, such as the B 3 ´ –CO 2, which has been found to distinguish glucuronic acid (GlcA) from iduronic acid (IdoA) in some HS tetrasaccharides. The previously observed diagnostic ions are generally not observed with 2- O- sulfo uronic acids or for more highly sulfated heparan sulfate tetrasaccharides. A recent study using electron detachment dissociation and principal component analysis revealed a series of ions that correlate with GlcA versus IdoA for a set of 2- O -sulfo HS tetrasaccharide standards. The present work comprehensively investigates the efficacy of these ions for assigning the C-5 stereochemistry of the reducing end uronic acid in 33 HS tetrasaccharides. A diagnostic ratio can be computed from the sum of the ions that correlate to GlcA to those that correlate to IdoA.
25
Molecular diversity of heparan sulfate
Jeffrey D. Esko, Ulf Lindahl · Journal of Clinical Investigation · 2001 · 821 citations
Jörg Kleeff, Toshiyuki Ishiwata, Asli Kumbasar et al. · Journal of Clinical Investigation · 1998 · 369 citations · Full text